Private Capital Group, LLC Galapagos Nv Transaction History

Private Capital Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$68.86 - $83.34 $18,592 - $22,501	-270 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$76.15 - $111.94 $4,645 - $6,828	61 Added 29.19%	270 $21,000
Q4 2020 Jan 26, 2021	SELL	$96.85 - $148.25 $2,614 - $4,002	-27 Reduced 11.44%	209 $21,000
Q3 2020 Nov 12, 2020	BUY	$122.47 - $213.56 $1,347 - $2,349	11 Added 4.89%	236 $33,000
Q1 2020 May 07, 2020	SELL	$143.0 - $274.03 $9,438 - $18,085	-66 Reduced 22.68%	225 $44,000
Q4 2019 Feb 14, 2020	BUY	$146.12 - $215.82 $6,429 - $9,496	44 Added 17.81%	291 $60,000
Q3 2019 Nov 13, 2019	BUY	$130.44 - $187.64 $29,740 - $42,781	228 Added 1200.0%	247 $38,000
Q2 2019 Aug 15, 2019	BUY	$111.45 - $128.93 $1,448 - $1,676	13 Added 216.67%	19 $2,000
Q1 2019 Apr 26, 2019	SELL	$89.61 - $117.78 $1,164 - $1,531	-13 Reduced 68.42%	6 $1,000
Q2 2018 Aug 09, 2018	SELL	$88.4 - $105.34 $6,630 - $7,900	-75 Reduced 79.79%	19 $1,000
Q1 2018 May 16, 2018	SELL	$94.51 - $120.23 $106,418 - $135,378	-1,126 Reduced 92.3%	94 $9,000
Q4 2017 May 18, 2018	BUY	$84.48 - $104.02 $97,152 - $119,623	1,150 Added 1642.86%	1,220 $9,000
Q4 2017 Mar 07, 2018	BUY	$84.48 - $104.02 $5,913 - $7,281	70	70 $4,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.76B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.